Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Stoke Therapeutics (STOK) Return on Assets (2022 - 2025)

Historic Return on Assets for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to 0.11%.

  • Stoke Therapeutics' Return on Assets rose 4600.0% to 0.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11%, marking a year-over-year increase of 4600.0%. This contributed to the annual value of 0.36% for FY2024, which is 800.0% up from last year.
  • Stoke Therapeutics' Return on Assets amounted to 0.11% in Q3 2025, which was up 4600.0% from 0.13% recorded in Q2 2025.
  • Stoke Therapeutics' Return on Assets' 5-year high stood at 0.15% during Q1 2025, with a 5-year trough of 0.5% in Q1 2024.
  • For the 4-year period, Stoke Therapeutics' Return on Assets averaged around 0.27%, with its median value being 0.37% (2023).
  • In the last 5 years, Stoke Therapeutics' Return on Assets tumbled by -1300bps in 2024 and then surged by 6500bps in 2025.
  • Stoke Therapeutics' Return on Assets (Quarter) stood at 0.38% in 2022, then decreased by -18bps to 0.45% in 2023, then increased by 30bps to 0.32% in 2024, then skyrocketed by 134bps to 0.11% in 2025.
  • Its Return on Assets stands at 0.11% for Q3 2025, versus 0.13% for Q2 2025 and 0.15% for Q1 2025.